Anthrax vaccine

US6770479B1 · kind B1 · utility

Assignee

• The United States of America as represented by the Secretary of the Army · US

Inventors

• John S. Lee · Hagerstown, US
• Peter Pushko · Frederick, US
• Michael Parker · Frederick, US
• Jonathan F. Smith · Cary, US
• Susan L. Welkos · Frederick, US

Key dates

• Filing date: Jul 9, 1999
• Grant date: Aug 3, 2004
• Expiry date: Jul 9, 2019

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2799/021
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Using the nontoxic PA protein from B. anthracis, a method and composition for use in inducing an immune response which is protective against anthrax in subjects is described.